Gland Pharma has informed that Jitendra Gangwal has been appointed as Vice-President (Research and Development), a Senior Management Personnel of the Company with effect from February 18, 2026. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are given in Annexure-A enclosed.
The above information is a part of company’s filings submitted to BSE.